[1] |
Vallabhajosyula S, Patlolla SH, Verghese D, et al. Burden of arrhythmias in acute myocardial infarction complicated by cardiogenic shock[J]. Am J Cardiol, 2020, 125(12):1774-1781.
doi: S0002-9149(20)30264-2
pmid: 32307093
|
[2] |
Shiyovich A, Axelrod M, Gilutz H, et al. Reply to: Predictors of early and late new-onset atrial fibrillation in the course of acute myocardial infarction[J]. Angiology, 2020, 71(2):194.
doi: 10.1177/0003319719881083
pmid: 31635483
|
[3] |
Khalfallah M, Elsheikh A. Incidence, predictors, and outcomes of new-onset atrial fibrillation in patients with ST-elevation myocardial infarction[J]. Ann Noninvasive Electrocardiol, 2020, 23(1):e12746.
|
[4] |
Jabre P, Jouven X, Adnet F, et al. Atrial fibrillation and death after myocardial infarction: a community study[J]. Circulation, 2011, 123(19):94-100.
|
[5] |
Büttner P, Schumacher K, Dinov B, et al. Role of NT-proANP and NT-proBNP in patients with atrial fibrillation: Association with atrial fibrillation progression phenotypes[J]. Heart Rhythm, 2018, 15(8):1132-1137.
doi: S1547-5271(18)30235-2
pmid: 29604419
|
[6] |
Karabağ Y, Rencuzogullari I, Çağdaş M, et al. Association between BNP levels and new-onset atrial fibrillation: A propensity score approach[J]. Herz, 2018, 43(6):548-554.
doi: 10.1007/s00059-017-4598-6
pmid: 28707026
|
[7] |
汪沁沁, 叶晨阳, 任雨笙, 等. 急性心肌梗死恢复期新发房颤的发生率与危险因素[J]. 心脏杂志, 2015, 27(5):585-587.
|
[8] |
Mazzone A, Scalese M, Paradossi U, et al. Development and validation of a risk stratification score for new-onset atrial fibrillation in STEMI patients undergoing primary percutaneous coronary intervention[J]. Int J Clin Pract, 2018, 72(4):e13087.
doi: 10.1111/ijcp.13087
URL
|
[9] |
Asanin M, Stankovic S, Mrdovic I, et al. B-type natriu-retic peptide predicts new-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention[J]. Peptides, 2012, 35(1):74-77.
doi: 10.1016/j.peptides.2012.02.022
URL
|
[10] |
Romanov A, Martinek M, Pürerfellner H, et al. Incidence of atrial fibrillation detected by continuous rhythm monitoring after acute myocardial infarction in patients with preserved left ventricular ejection fraction: results of the ARREST study[J]. Europace, 2018, 20(2):263-270.
doi: 10.1093/europace/euw344
URL
|
[11] |
Congo KH, Belo A, Carvalho J, et al. New-onset atrial fibrillation in ST-segment elevation myocardial infarction: Predictors and impact on therapy and mortality[J]. Arq Bras Cardiol, 2019, 113(5):948-957.
doi: S0066-782X2019001100948
pmid: 31553385
|
[12] |
Shiyovich A, Axelrod M, Gilutz H, et al. Early versus late new-onset atrial fibrillation in acute myocardial infarction: Differences in clinical characteristics and predictors[J]. Angiology, 2019, 70(10):921-928.
doi: 10.1177/0003319719867542
pmid: 31387358
|
[13] |
Kondo Y, Kobayashi Y. New-onset atrial fibrillation after atrial ischemia[J]. J Arrhythm, 2019, 35(6):863-864.
doi: 10.1002/joa3.12233
URL
|
[14] |
Stępień-Wałek A, Woźakowska-Kapłon B. The effect of left ventricular diastolic function on the secretion of B-type natriuretic peptide at rest and directly after exercise test in asymptomatic patients with diabetes or after myo-cardial infarction with preserved left ventricular systolic functi[J]. Kardiol Pol, 2016, 74(6):529-536.
doi: 10.5603/KP.a2015.0216
pmid: 26575310
|